Print

Orchid Chemicals & Pharmaceuticals Ltd.
Unaudited Financial Results for three months ended June 30, 2007
(Rs.Lakhs)
   
Standalone Accounts
Consolidated Accounts
S.No
Particulars
Three months ended
30-June-07
(Unaudited)
Three months ended
30-June-06
(Unaudited)
Year ended 31-Mar-07 (Audited)
Three months ended 30-June-07 (Unaudited)
Three months ended 30-June-06 (Unaudited)
Year ended 31-Mar-07 (Audited)
1
 Sales and Operating Income
23819.64
20170.98
93417.55
25176.97
21264.90
98508.07
2
 Other Income
30.09
78.14
155.98
-
74.99
35.62
3
 Exchange Gain on FCCBs
5286.18
-
-
5286.18
-
-
4
 Total Income (1+2+3)
29135.91
20249.11
93573.52
30463.15
21339.89
98543.68
5
Total Expenditure
17598.14
14369.81
64436.98
19111.08
15741.86
70849.98
a) Decrease/(Increase) in Stock in trade
(3190.97)
(3348.94)
(14012.10)
(3676.10)
(3481.59)
(13745.93)
b) Material Cost
10132.64
11078.64
45067.65
11600.12
12183.28
49109.64
c) Staff Cost
2227.48
1717.67
7772.57
2611.77
1887.39
9244.65
d) Other Expenditure
8428.99
4922.44
25608.85
8575.29
5152.78
26241.62
6
Profit before Interest, Depreciation
11537.77
5879.31
29136.55
11352.06
5598.03
27693.71
7
 Interest and Finance Charges
1648.16
2202.85
9830.65
1671.34
2231.53
9929.14
8
 Depreciation / Amortisation
2298.76
1932.37
8246.73
2359.74
1998.26
8508.93
9
 Profit before tax (6-7-8)
7590.85
1744.09
11059.16
7320.99
1368.23
9255.63
10
 Provision for Taxation
    Current Tax
860.05
-
-
860.05
-
-
    Deferred Tax
1560.00
250.00
1230.00
1560.00
250.00
1230.00
    Fringe Benefit Tax
41.00
35.00
166.00
42.00
35.00
166.00
11
 Net Profit (9-10)
5129.80
1459.07
9663.16
4858.94
1083.23
7859.63
12
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
6582.24
6581.17
6581.63
6582.24
6581.17
6581.63
13
 Reserves excluding Revaluation Reserves
43542.57
41928.64
14
 Basic Earnings per Share (EPS) Rs.*
7.79*
2.22*
14.70
7.38*
1.65*
11.96
15
 Diluted Earnings per Share (EPS) Rs.*
5.23*
1.98*
13.23
4.96*
1.47*
10.76
16
Aggregate of Public Shareholding
 

Number of equity shares
50208204
54264568
50833619
  Percentage of Shareholding
76.28
82.46
77.24
   
* EPS is for the period (not annualised)
  • The above financial results were taken on record by the Board of Directors at its meeting held on Thursday, July 19, 2007.
  • The Company is operating in single segment (i.e) "Pharmaceuticals".
  • Exchange gain on outstanding Foreign Currency Convertible Bonds (FCCBs)for the Quarter is Rs. 5286.18 lakhs. There is an additional current and deferred tax provision of Rs.1908.92 lakhs on account of the above exchange gain and the net impact on the profit after tax is Rs. 3377.26 lakhs.
  • In accordance with the revised AS 15, necessary provision has been made for the employee benefits during the period. The increase in liability as at the commencement of the year as per revised AS 15 will be adjusted against the opening reserves in accordance with the said standard.
  • The standalone accounts have been subjected to limited review by the Statutory Auditors.
  • The Allotment Committee of the Board has allotted :
    - 6085 shares (375 shares at an adjusted price of Rs.162.24 per share, 210 shares at an adjusted price of Rs. 168.00 per share and
    5,500 shares at an adjusted price of Rs.200.44 per share) to employees under ORCHID ESOP 1999 Scheme on May 03, 2007.
    - 5650 shares at an adjusted price of Rs.200.44 per share, to employees under ORCHID ESOP 1999 Scheme on July 17, 2007.
  • The Company received 11 complaints during the quarter ended June 30, 2007 from the shareholders. All the complaints have been resolved and no complaints were pending as on June 30, 2007.
  • Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : July 19, 2007

For and on behalf of the Board

K.Raghavendra Rao
Managing Director